No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
KFY Korn Ferry
- 65.580
- +0.130+0.20%
Close May 22 16:00 ET
- 65.500
- -0.080-0.12%
Post 18:22 ET
3.42BMarket Cap22.69P/E (TTM)
65.855High65.200Low175.54KVolume65.320Open65.450Pre Close11.50MTurnover0.34%Turnover Ratio16.60P/E (Static)52.18MShares69.33252wk High2.01P/B3.36BFloat Cap43.97652wk Low0.84Dividend TTM51.24MShs Float81.903Historical High1.28%Div YieldTTM1.00%Amplitude5.015Historical Low65.521Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Korn Ferry to Participate in the Baird 2024 Global Consumer, Technology and Services Conference
LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE: KFY) today announced the company's participation in the Baird 2024 Global Consumer, Technology and Services Conference on Wednesday, June 5th, 2024.Korn
Korn Ferry's (NYSE:KFY) Intrinsic Value Is Potentially 18% Below Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Korn Ferry fair value estimate is US$53.55 Current share price of US$65.69 suggests Korn Ferry is potentially 23% overvalued Analyst price
Calibre Mining Says Korn Ferry Retained to Conduct Chief Fincl Officer Replacement Search >CXB.T
Calibre Mining Says Korn Ferry Retained to Conduct Chief Fincl Officer Replacement Search >CXB.T
Is Korn Ferry (NYSE:KFY) Expensive For A Reason? A Look At Its Intrinsic Value
Korn Ferry Ranked as America's Best Executive Recruiter by Forbes Magazine
Company Also Named a Top Professional Search FirmLOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE: KFY) has been recognized by Forbes Magazine as America's best executive recruiting firm – a top ranking
Simmons Bank Open for the Snedeker Foundation Relocating to Vanderbilt Legends Club Beginning 2024
Korn Ferry Tour (PRNewsfoto/Simmons Bank) Simmons Bank Open for the Snedeker Foundation (PRNewsfoto/Simmons Bank)
Comments
Investors' expectations of strong future growth justify Korn Ferry's high P/E ratio. The potential for a deterioration in earnings is not seen as significant enough to warrant a lower P/E ratio.
Getting In Cheap On Korn Ferry (NYSE:KFY) Might Be DifficultKorn Ferry's reinvestment accompanied by falling return prompts analysts to believe investors are considering this. They suggest seeking multi-bagger opportunities elsewhere.
$Market Beating Value ETF(PFL1021127)$
My paperfolio’s link can be seen above. The stocks I pick are based on value investing philosophy. I won’t go into what that means in this post. I’m a lot more conservative than your average investor. As such, this portfolio only used 50-60% of its cash to buy stocks, while the rest sat idle. In other words, I am up 13% at the time of writing mostly using only 50-75% of my portfolio’s cash (with some exceptions). As I have seen bu...
My paperfolio’s link can be seen above. The stocks I pick are based on value investing philosophy. I won’t go into what that means in this post. I’m a lot more conservative than your average investor. As such, this portfolio only used 50-60% of its cash to buy stocks, while the rest sat idle. In other words, I am up 13% at the time of writing mostly using only 50-75% of my portfolio’s cash (with some exceptions). As I have seen bu...
8
Gainers:
• $La-Z-Boy(LZB.US$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US$)
• $Ikena Oncology(IKNA.US$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
• $La-Z-Boy(LZB.US$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US$)
• $Ikena Oncology(IKNA.US$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
8
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg